Mylan wins dismissal of kansas epipen® direct purchaser case

Pittsburgh, july 27, 2021 /prnewswire/ -- viatris (nasdaq: vtrs) today announced that the u.s. district court for the district of kansas granted mylan's motion to dismiss in a lawsuit brought against it and pfizer by kph healthcare services, inc. (kph) on behalf of an asserted class of direct purchasers of epipen® products. the court agreed with the company's argument that kph lacked the legal standing to assert the claims in its lawsuit and dismissed the case in its entirety with an option for kph to file a limited amended complaint within 30 days.
VTRS Ratings Summary
VTRS Quant Ranking